Leading Innovation

For more than 40 years, we have committed to transforming diabetes care.

Exciting news!

|

We’ve filed a License Application with Health Canada for the MiniMedTM 780G and GuardianTM 4 sensor. Please keep in mind that Health Canada has a period for reviewing the file and issuing a license if the information meet the requirements. This process can take some time and we will provide updates when available.

Did you know

The MiniMedTM 770G system is enabled for future software upgrades.

MiniMed is currently the only manufacturer that has software updates for both pump and CGM*, and, in fact, our future goals include significant innovations with both products.

Our goal for the future is aimed at developing technologies that are:

Simpler

Simplify diabetes management

Smarter 

Develeop predictives analytics that adapt to inividual needs

Smaller

Create more discreet products

Planned future product innovation and goals

All referenced product innovations are in development. Such innovations are not licensed for sale in Canada and will require Health Canada review and licencing prior to being made available for sale.

† Investigational. Not licensed for sale in Canada for any use and not commercially available in Canada.
†† In development. Potential future technology. Not licensed for sale in Canada and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of individual countries and regions and are  not guaranteed.